<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03559920</url>
  </required_header>
  <id_info>
    <org_study_id>4-2018-0065</org_study_id>
    <nct_id>NCT03559920</nct_id>
  </id_info>
  <brief_title>The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head &amp; Neck Surgery</brief_title>
  <official_title>The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head &amp; Neck Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sedation in the ICUs is very common. There is no ideal sedative yet, so research has been
      conducted to replace propofol and midazolam, which are the most commonly used sedatives in
      ICUs, by inhalation anesthetics. The investigators will sedate the patients who undergo head
      &amp; neck surgery with tracheostomy for several days using sevoflurane, a kind of inhalation
      agent, via anesthetic conserving device.

      The objective of this study is to confirm the end-tidal sevoflurane concentration for
      inducing moderate sedation (RASS -2~-3). In addition, the investigators compare the volatile
      sedation with the IV(intravenous) sedation to see if the volatile sedation could reduce the
      amount of post-operative opioid consumption.

        -  RASS: Richmond Agitation-Sedation Scale

        -  RASS: Richmond Agitation-Sedation Scale
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When patients, who need mechanical ventilation for several days after head &amp; neck surgery,
      enters the ICU, the investigators induce moderate sedation (RASS -2~-3). End-tidal
      sevoflurane (etSEVO) concentration is adjusted to 0.5Vol% within 30 minutes. Sedation level
      is evaluated every 5 minutes. After 30 minutes, the investigators check that the sedation
      goal is achieved.

      Following the up &amp; down method, if the moderate sedation (RASS -2~-3) or the deep sedation
      (RASS -4~-5) is achieved at the etSEVO concentration of 0.5vol% after 30 minutes of sedation,
      the next patient's target etSEVO concentration is reduced to 0.4vol%. On the contrary to
      this, if only light sedation (RASS above -1) is achieved, the next patient's target etSEVO is
      increased to 0.6vol%. This process is repeated to find the appropriate etSEVO concentration
      at the beginning of sedation, which induces sedation of RASS -2~-3.

      In retrospective analysis, the investigators compared the prospective study group with
      propofol intravenous sedation group.

      * RASS: Richmond Agitation-Sedation Scale
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 3, 2018</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Optimal end-tidal sevoflurane concentration to induce moderate sedation of RASS -2~-3 in patients who undergo head &amp; neck surgery with tracheostomy</measure>
    <time_frame>After the first 30 minutes after sedation with sevoflurane via anesthetic conserving device</time_frame>
    <description>Investigators will find the initial concentration of sevoflurane for proper sedation by the Dixon's up and down method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the sevoflurane group and the intravenous sedation group: Compare the ICU stay</measure>
    <time_frame>within the 3 days (plus of minus 3 days) after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the sevoflurane group and the intravenous sedation group: Compare the hospital day</measure>
    <time_frame>within the 3 days (plus of minus 3 days) after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the sevoflurane group and the intravenous sedation group: Compare the incidence of delirium, hypotension</measure>
    <time_frame>within the 3 days (plus of minus 3 days) after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the sevoflurane group and the intravenous sedation group: Compare the remifentanil infusion dose</measure>
    <time_frame>within the 3 days (plus of minus 3 days) after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Patients Who Needs Sedation After Head &amp; Neck Surgery</condition>
  <arm_group>
    <arm_group_label>Sevoflurane group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who are sedated using sevoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous sedation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who are sedated using propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sedate using sevoflurane via anesthetic conserving device(ACD, Anaconda®) after surgery</intervention_name>
    <description>The investigators sedate the patients in the ICU for several days after head &amp; neck surgery using sevoflurane via anesthetic conserving device in sevoflurane group.</description>
    <arm_group_label>Sevoflurane group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sedate using propofol.</intervention_name>
    <description>Retrospectively, the investigators compare the sevoflurane group with intravenous sedation group using propofol.</description>
    <arm_group_label>Intravenous sedation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who needs sedation in the ICU for several days after head &amp; neck surgery

          -  ASA class I~III

          -  Adult patients over 20 years old

          -  Patients who can read and understand the informed consent

        Exclusion Criteria:

          -  Patients who do not agree to participate in the study

          -  Past history or Family history of malignant hyperthermia

          -  End stage renal disease (eGFR&lt;30 or dialysis)

          -  Moderate to severe liver disease (AST, ALT &gt; 200IU/L)

          -  Pregnant women

          -  Patients who cannot read and understand the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 1, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

